Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Lowered to $250 at Jefferies

November 3, 2021 8:03 AM
Jefferies analyst Michael Yee lowered the price target on Amgen (NASDAQ: AMGN) to $250.00 (from $270.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles